IRMD - IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference | Benzinga
WINTER SPRINGS, Fla., Jan. 02, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the "Company") (NASDAQ:IRMD), a leader in developing innovative Magnetic Resonance Imaging ("MRI") compatible medical devices, today announced that the Company will be participating in the upcoming 42nd Annual J.P. Morgan Healthcare Conference.
Iradimed's CEO, Roger Susi, is scheduled to present on Thursday, January 11, 2024, at 12:00 p.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the "Events and Presentations" section of the Company's investor website at https://www.iradimed.com/investors/events.
About IRADIMED CORPORATION
IRADIMED CORPORATION is a leader in developing innovative Magnetic Resonance Imaging ("MRI") compatible medical devices. We design, manufacture, market, and distribute MRI-compatible medical devices, accessories, disposables, and related services.
We are the only provider of a non-magnetic intravenous ("IV") infusion pump system designed to be safe during MRI procedures. ...